NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
Sign in Subscribe

Travelers Beats Earnings Estimates but Shares Drop on Higher Catastrophe Losses

Travelers delivered a strong third-quarter profit and beat consensus, but higher storm losses and flat premium growth weighed on the stock.

Travelers Beats Earnings Estimates but Shares Drop on Higher Catastrophe Losses
Credit: The Travelers Companies
Already have an account? Sign in.
Featured/ 10/16/2026 · 8:33 AM
TRV
/ Don’t stop at just one post.

Related↓

Travelers Delivers Standout Q2 Results as Core Income Nearly Doubles Estimates
Featured/ 07/17/2026 · 11:02 AM

Travelers Delivers Standout Q2 Results as Core Income Nearly Doubles Estimates

Lower catastrophe losses and strong investment income drove the results.

/ Subscriber only
/ Read more

Feed↓

Amid Nasdaq’s Worst Week in a Year, Three New Listings Stand Out
10/16/2026 · 4:35 PM

Amid Nasdaq’s Worst Week in a Year, Three New Listings Stand Out

Two biotech IPOs and an AI infrastructure stock rose sharply on their early trading days even as the Nasdaq tumbled on broader tech weakness.

/ Subscriber only
Novartis Ends Mid-Stage Fabhalta Trial in Lupus Nephritis Citing Strategic Considerations
Featured/ 10/16/2026 · 3:01 PM

Novartis Ends Mid-Stage Fabhalta Trial in Lupus Nephritis Citing Strategic Considerations

The drug remains approved for other kidney diseases.

/ Subscriber only
Tesla-SpaceX Merger Odds Top 50% as Barclays Sees Possible Deal Before December Meeting
Featured/ 10/16/2026 · 12:05 PM

Tesla-SpaceX Merger Odds Top 50% as Barclays Sees Possible Deal Before December Meeting

Kalshi traders now price in a greater-than-even chance of a Tesla–SpaceX merger by spring 2027 following the Roadster debut.

/ Subscriber only
Explore
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
More
  • Sign up
  • Sign in
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Terms/Privacy
  • UP↑
Get alerts

Be the first to know when deals break, stocks move, or biotech headlines hit.

Email address Subscribe
DON'T FALL BEHIND. ©2026
For informational purposes only. Not financial advice.
NOTRELOAD AI